Vimarsana
Biggest News Aggregation in the World

Page 46 - Adverse Effects News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adverse Effects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adverse Effects Today - Breaking & Trending Today

Dupilumab's Versatility Shown in Off-Label Uses - Vimarsana News

Dupilumab's Versatility Shown in Off-Label Uses

With increased use by specialists, more primary care patients are taking the drug.

Analysis Reveals Recent Acne Prescribing Trends - Vimarsana News

Analysis Reveals Recent Acne Prescribing Trends

The study found that for women with acne, prescriptions for spironolactone increased about three- to fourfold during the study period among all clinician types.

Do the Data Support Psychedelics in Addiction Therapy? - Vimarsana News

Do the Data Support Psychedelics in Addiction Therapy?

Although psychedelics show promise for treating alcohol and tobacco use disorders, many doctors have the misperception that the drugs are highly dangerous.

Botulinum Toxin Daxxify Gets FDA Nod for Cervical Dystonia - Vimarsana News

Botulinum Toxin Daxxify Gets FDA Nod for Cervical Dystonia

The FDA grants daxibotulinumtoxinA-lanm injection (Daxxify, Revance Therapeutics) a therapeutic indication for treatment of cervical dystonia in adults.

Immune Issues After Adjuvant Anti–PD-1 Therapy in Melanoma - Vimarsana News

Immune Issues After Adjuvant Anti–PD-1 Therapy in Melanoma

Chronic immune-related adverse events often persist years after adjuvant anti–PD-1 immunotherapy for high-risk melanoma and may require prolonged monitoring and management, researchers say.